Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01484028 · ClinicalTrials.gov registry record · NA
Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens
A NA study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 275
- Enrollment target
NCT01484028: Completed NA study, sponsored by Johnson & Johnson Vision Care.
NCT01484028 is a NA study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 275 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01484028, a NA study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 275 participants
- Enrollment target
Study Summary
This study will serve to evaluate and compare the performance of two new lenses to a marketed lens.
Primary Outcome
Monocular distance Snellen visual acuity (VA) scores were coverted to the algorithm of the minimal angle of resolution (LogMAR) scale based on the following formula: LogMAR = Log10 (VA/20) - a\*VAR, where Log10 = base 10 logarithm, VA = the Snellen denominator score, a = LogMAR stepsize coefficient and VAR = letter gained or missing in addition to the Snellen denominator score.
Interventions
- DEVICE etafilcon A control lens (1DM)
- DEVICE etafilcon A with print and PVP for light eyes (EALE)
- DEVICE etafilcon A with print and PVP for dark eyes (EADE)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2011-11 |
| Est. Completion | 2012-02 |
| Phase | NA |
What the finished NCT01484028 record still lists
NCT01484028 is an interventional study that assigns participants to a tested intervention. The registered 275 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 3 interventions - of which etafilcon A control lens (1DM) is the first listed.
NCT01484028 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01484028 about?
NCT01484028 is a clinical study titled "Evaluation of the Performance of Two Contact Lenses Compared to a Marketed Lens". This study will serve to evaluate and compare the performance of two new lenses to a marketed lens.
What is the current status of trial NCT01484028?
This trial is currently completed. It is a NA study. The enrollment target is 275 participants. The study started on 2011-11. Estimated completion is 2012-02.
What interventions are being tested in trial NCT01484028?
The interventions under investigation include: etafilcon A control lens (1DM) (DEVICE), etafilcon A with print and PVP for light eyes (EALE) (DEVICE), etafilcon A with print and PVP for dark eyes (EADE) (DEVICE).
Who is sponsoring clinical trial NCT01484028?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01484028's enrollment target sits among peer trials
275 383rd of 2000 higher than 1,616 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269190 · 275 participants · NA
Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery
- NCT01900132 · 275 participants · NA
Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers
- NCT04104776 · 275 participants · Phase 1
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- NCT04765150 · 275 participants
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia